Trusted Resources: Education
Scientific literature and patient education texts
Early and Late Brain Resonance Findings of Two Siblings With Hunter Syndrome
source: Revista de Neurologia
year: 2021
authors: Silvestre-Avendaño JJ,Morales-Vásquez DE,Muñoz-Zuñiga JR
summary/abstract:Mucopolysaccharidosis type II (MPS II) is a lysosomal disease caused by deficiency of the enzyme iduronate-2-sulfatase (IDS), linked to the X chromosome, producing a wide spectrum of clinical manifestations.
organization: Universidad Nacional de Colombia, Bogotá DC, Colombia.DOI: 10.33588/rn.7301.2021203
read more
BookmarkRelated Content
-
Otorhinolaryngological Management in Taiwanese Patients With MucopolysaccharidosesMucopolysaccharidoses (MPSs) are lysosom...
-
CHOC-Harbor UCLA MPS Multidisciplinary CenterCHOC and Harbor-UCLA Pediatrics together...
-
Real-World Data Assessment of Safety of Home-Based and Hospital/Outpatient-Based laronidase Enzyme Replacement Thera...Enzyme replacement therapy (ERT) is avai...
-
Convergent Molecular Mechanisms Underlying Cognitive Impairment in Mucopolysaccharidosis Type IIMucopolysaccharidosis type II (MPS II) i...
-
Mucopolysaccharidosis Type 1 (MPS 1)What is Mucopolysaccharidosis Type 1?Muc...
-
MPSBase: Comprehensive Repository of Differentially Expressed Genes for MucopolysaccharidosesMucopolysaccharidoses (MPS) are lysosoma...
-
A Rare Specialism: A Look at the Last Ten Years in MPS Management, Presented by Dr Christina Lampehttps://www.youtube.com/watch?v=EjNEVoWT...
Powered by
